(Q40479416)

20 September 2017

title

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. (English)

1 reference

20 September 2017

0 references

1 reference

Athanassios Argiris

1

1 reference

20 September 2017

Yi Li

series ordinal

2

1 reference

20 September 2017

Arlene Forastiere

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

20 September 2017

1 reference

20 September 2017

volume

101

1 reference

20 September 2017

issue

10

1 reference

20 September 2017

page(s)

2222-2229

1 reference

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

The design of phase III palliative chemotherapy trials in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20640

7 January 2021

Identifiers

DOI

10.1002/CNCR.20640

1 reference

20 September 2017

1 reference